185 related articles for article (PubMed ID: 30148659)
1. Clinical Significance of 4L Lymph Node Dissection in Left Lung Cancer.
Wang YN; Yao S; Wang CL; Li MS; Sun LN; Yan QN; Tang SW; Zhang ZF
J Clin Oncol; 2018 Oct; 36(29):2935-2942. PubMed ID: 30148659
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.
Liu C; Wei S; Guo C; Mei J; Pu Q; Liu L
Ann Surg Oncol; 2021 Jan; 28(1):194-202. PubMed ID: 32638165
[TBL] [Abstract][Full Text] [Related]
3. Predictors and survival impact of station 4L metastasis in left non-small cell lung cancer.
Fang L; Wang L; Wang Y; Wu Y; Ye P; Lv W; Hu J
J Cancer Res Clin Oncol; 2019 May; 145(5):1313-1319. PubMed ID: 30877377
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer.
Zhou D; Yue D; Zhang Z; Tian P; Feng Y; Liu Z; Zhang B; Wang M; Zhao X; Wang C
World J Surg Oncol; 2022 Jul; 20(1):222. PubMed ID: 35778770
[TBL] [Abstract][Full Text] [Related]
5. Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.
Deng HY; Li D; Qiu XM; Zhu DX; Tang X; Zhou Q
ANZ J Surg; 2021 Nov; 91(11):E696-E702. PubMed ID: 34405519
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological characteristics and risk factors of station 4L lymph node metastasis of left non-small cell lung cancer].
Shen L; Yun T; Guo J; Liu Y; Liang C
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1793-1798. PubMed ID: 33380404
[TBL] [Abstract][Full Text] [Related]
7. Survival Benefit of Left Lower Paratracheal (4L) Lymph Node Dissection for Patients with Left-Sided Non-small Cell Lung Cancer: Once Neglected But of Great Importance.
Zhao K; Wei S; Mei J; Guo C; Hai Y; Chen N; Liu L
Ann Surg Oncol; 2019 Jul; 26(7):2044-2052. PubMed ID: 31011902
[TBL] [Abstract][Full Text] [Related]
8. Significance of risk factor analysis and dissection for station 4L lymphatic metastasis in left lung cancer: a systematic review and meta-analysis.
Wang CX; Xu C; Li C; Ding C; Chen J; Zhao J
Transl Cancer Res; 2021 Apr; 10(4):1656-1666. PubMed ID: 35116491
[TBL] [Abstract][Full Text] [Related]
9. The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer.
Wo Y; Li H; Zhang Y; Peng Y; Wu Z; Liu P; Shang Y; Hu H; Zhang Y; Xiang J; Sun Y
Lung Cancer; 2022 Aug; 170():141-147. PubMed ID: 35780588
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of 206 station lymph node in transverse colon cancer.
Xu YX; Huang Y; Wang XJ; Ye DX; Chi P
Cancer Med; 2022 Jun; 11(12):2366-2376. PubMed ID: 35437894
[TBL] [Abstract][Full Text] [Related]
11. Mediastinal lymph node evaluation, especially at station 4L, in left upper lobe lung cancer.
Hanaoka J; Yoden M; Okamoto K; Kaku R; Ohshio Y
J Thorac Dis; 2022 Sep; 14(9):3321-3334. PubMed ID: 36245624
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and survival outcomes of 4L lymph node dissection in left lung adenocarcinoma and squamous cell carcinoma.
Shen L; Guo J; Zhang W; Liang C; Chen H; Liu Y
Front Oncol; 2023; 13():1124014. PubMed ID: 37114135
[TBL] [Abstract][Full Text] [Related]
13. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
[TBL] [Abstract][Full Text] [Related]
15. Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: A propensity score matching study.
Yang MZ; Tan ZH; Li JB; Long H; Fu JH; Zhang LJ; Lin P; Hou X; Yang HX
Thorac Cancer; 2022 Aug; 13(15):2106-2116. PubMed ID: 35702992
[TBL] [Abstract][Full Text] [Related]
16. Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis.
Kuroda H; Sakao Y; Mun M; Uehara H; Nakao M; Matsuura Y; Mizuno T; Sakakura N; Motoi N; Ishikawa Y; Yatabe Y; Nakagawa K; Okumura S
PLoS One; 2015; 10(8):e0134674. PubMed ID: 26247881
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of 4L lymph node dissection in left-side operable non-small-cell lung cancer: a meta-analysis.
Peng L; Huang KL; Shang QW; Wang Y; Li W
Updates Surg; 2024 Jan; 76(1):23-32. PubMed ID: 37938527
[TBL] [Abstract][Full Text] [Related]
18. The impact of left lower paratracheal (4L) lymph node dissection on survival in patients with surgically treated left-sided NSCLC.
Gryszko GM; Cackowski MM; Zbytniewski M; Woźnica K; Orłowski TM; Dziedzic DA;
Eur J Cardiothorac Surg; 2021 Nov; 60(5):1201-1209. PubMed ID: 34279610
[TBL] [Abstract][Full Text] [Related]
19. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
